SEC Company Response from DERMA SCIENCES, INC. (CIK 0000892160) — Jun 14, 2005
DERMA SCIENCES, INC. (CIK 0000892160)
Date: June 14, 2005 · CIK: 0000892160 · Accession: 0001088020-05-000046
AI Filing Summary & Sentiment
File numbers found in text: 333-123940
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
June 14, 2005
VIA EDGAR
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Jeffrey Riedler, Esq.
Assistant Director
Division of Corporate Finance
Re: Derma Sciences, Inc.
Acceleration Request for Registration Statement on Form S-3
Filed April 8, 2005
File No. 333-123940
Ladies and Gentlemen:
We respectfully request acceleration of the effective date of our
above-captioned registration statement on Form S-3 under the Securities Act of
1933 to 3:30 p.m. EDT on Tuesday, June 14, 2005, or as soon after that as
practicable. We also acknowledge the following:
1. Should the Commission or the staff, acting pursuant to delegated
authority, declare the filing effective, it does not foreclose the
Commission from taking any action with respect to the filing;
2. The action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the
Registrant from its full responsibility for the adequacy and accuracy of the
disclosures in the filing; and
3. The Registrant may not assert this action as a defense in any proceeding
by the Commission or any person under the federal securities laws of the
United States.
Very truly yours,
DERMA SCIENCES, INC.
By: /s/Edward J. Quilty
----------------------
Edward J. Quilty
President and Chief Executive Officer
</TEXT>
</DOCUMENT>